|
HECTD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.63753513158372E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.07929245938021E-12 |
| Normal-vs-Stage2 |
1.82920000002529E-06 |
| Normal-vs-Stage3 |
5.614000E-04 |
| Normal-vs-Stage4 |
7.541800E-03 |
| Stage1-vs-Stage2 |
7.275400E-01 |
| Stage1-vs-Stage3 |
2.718000E-01 |
| Stage1-vs-Stage4 |
9.182600E-01 |
| Stage2-vs-Stage3 |
6.134400E-01 |
| Stage2-vs-Stage4 |
8.907800E-01 |
| Stage3-vs-Stage4 |
6.216400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.39304148613928E-12 |
| Normal-vs-AfricanAmerican |
7.93919999741988E-08 |
| Normal-vs-Asian |
4.382300E-03 |
| Caucasian-vs-AfricanAmerican |
4.619200E-01 |
| Caucasian-vs-Asian |
6.138600E-01 |
| AfricanAmerican-vs-Asian |
8.251200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7892354264859E-12 |
| Normal-vs-Female |
2.602700E-04 |
| Male-vs-Female |
9.241400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.45950000005357E-06 |
| Normal-vs-Extreme_Weight |
1.73816516735315E-12 |
| Normal-vs-Obese |
1.41080000004568E-06 |
| Normal-vs-Extreme_Obese |
1.15940000000592E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.977180E-01 |
| Normal_Weight-vs-Obese |
5.123200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.166400E-01 |
| Extreme_Weight-vs-Obese |
1.294220E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.614400E-01 |
| Obese-vs-Extreme_Obese |
2.505000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.281800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.65010005659383E-10 |
| Normal-vs-Age(61-80Yrs) |
2.07045491862345E-12 |
| Normal-vs-Age(81-100Yrs) |
7.37140004591907E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.955830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.007800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.286300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.119800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.220380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.650200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63025148935958E-12 |
| Normal-VS-Type2 PRCC |
4.32979996300986E-09 |
| Normal-VS-KIRP CIMP |
7.069600E-01 |
| Normal-VS-Unclassified PRCC |
1.9749999999874E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.091400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.607700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.401550E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.191900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.284000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.600400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.01900734914307E-13 |
| Normal-vs-N1 |
9.374200E-02 |
| Normal-vs-N2 |
1.037650E-04 |
| N0-vs-N1 |
8.695200E-03 |
| N0-vs-N2 |
7.124200E-01 |
| N1-vs-N2 |
1.765450E-01 |
|
|
